← Eichor
Study identifier: NCT06550284 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing

Condition: Carpal Tunnel Syndrome  ·  Sponsor: Brooke Army Medical Center

PhaseNA
Planned participants48
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The diagnosis of carpal tunnel syndrome (CTS) is typically based on clinical findings and confirmatory electrodiagnostic testing. However, electrodiagnostic testing can only assess large A-alpha and A-beta nerve fibers. Quantitative sensory testing (QST) is a series of tests used to assess small nerve fiber changes in the A-delta, c-fibers, and A-beta nerve fibers as well. Previous studies have used QST to assess small nerve fiber changes related to carpal tunnel syndrome and found changes compared to controls. This study will utilize a course of standard physical therapy care and assess for any changes to small nerve fiber activity and how those changes may or may not relate to patient outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Cortney C Shewmaker, DPT  ·  417-766-7414  ·  cortney.c.shewmaker.mil@health.mil

Always discuss trial participation with your own doctor first.

Locations (1)

Brooke Army Medical CenterSan Antonio, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06550284